Litcius/Paper detail

MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection

Qi Guo, Yongjie Zhang, Junsheng Fan, Haonan Zhang, Zhemin Zhang, Bing Li, Haiqing Chu

2021Antimicrobial Agents and Chemotherapy19 citationsDOIOpen Access PDF

Abstract

Macrolide resistance is always a concern when treating Mycobacterium abscessus infections. MAB_2355c was identified previously as a possible new factor that confers the intrinsic resistance of 194 clinical M. abscessus isolates to clarithromycin.

Topics & Concepts

ComplementationMycobacterium abscessusBiologyRibosomeMicrobiologyMolecular biologyMonoclonal antibodyMycobacteriumGeneBiochemistryMutantGeneticsRNABacteriaAntibodyMycobacterium research and diagnosisTuberculosis Research and EpidemiologyActinomycetales infections and treatment
MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection | Litcius